Stöhr W - Search Results

1

Interleukin-6 and D-dimer levels at seroconversion as predictors of HIV-1 disease progression.

Hamlyn E, Fidler S, Stöhr W, Cooper DA, Tambussi G, Schechter M, Miro JM, Mcclure M, Weber J, Babiker A, Porter K; SPARTAC Trial Investigators. Hamlyn E, et al. Among authors: stohr w. AIDS. 2014 Mar 27;28(6):869-74. doi: 10.1097/QAD.0000000000000155. AIDS. 2014. PMID: 24300544 Clinical Trial.

2

HIV-1 DNA predicts disease progression and post-treatment virological control.

Williams JP, Hurst J, Stöhr W, Robinson N, Brown H, Fisher M, Kinloch S, Cooper D, Schechter M, Tambussi G, Fidler S, Carrington M, Babiker A, Weber J, Koelsch KK, Kelleher AD, Phillips RE, Frater J; SPARTACTrial Investigators. Williams JP, et al. Among authors: stohr w. Elife. 2014 Sep 12;3:e03821. doi: 10.7554/eLife.03821. Elife. 2014. PMID: 25217531 Free PMC article.

3

The effect of short-course antiretroviral therapy initiated in primary HIV-1 infection on interleukin-6 and D-dimer levels.

Hamlyn E, Stöhr W, Cooper DA, Fisher M, Tambussi G, Schechter M, Miro JM, Vanobberghen F, Babiker A, Weber J, Mcclure M, Porter K, Fidler S; SPARTAC Investigators. Hamlyn E, et al. Among authors: stohr w. AIDS. 2015 Jul 17;29(11):1355-61. doi: 10.1097/QAD.0000000000000675. AIDS. 2015. PMID: 25870986 Free article.

4

Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy.

Stöhr W, Fidler S, McClure M, Weber J, Cooper D, Ramjee G, Kaleebu P, Tambussi G, Schechter M, Babiker A, Phillips RE, Porter K, Frater J. Stöhr W, et al. PLoS One. 2013 Oct 25;8(10):e78287. doi: 10.1371/journal.pone.0078287. eCollection 2013. PLoS One. 2013. PMID: 24205183 Free PMC article. Clinical Trial.

5

Factors associated with virological rebound in HIV-infected patients receiving protease inhibitor monotherapy.

Stöhr W, Dunn DT, Arenas-Pinto A, Orkin C, Clarke A, Williams I, Johnson M, Beeching NJ, Wilkins E, Sanders K, Paton NI; Protease Inhibitor Monotherapy Versus Ongoing Triple Therapy (PIVOT) Trial Team. Stöhr W, et al. AIDS. 2016 Nov 13;30(17):2617-2624. doi: 10.1097/QAD.0000000000001206. AIDS. 2016. PMID: 27456983 Clinical Trial.

6

Post-treatment control or treated controllers? Viral remission in treated and untreated primary HIV infection.

Martin GE, Gossez M, Williams JP, Stöhr W, Meyerowitz J, Leitman EM, Goulder P, Porter K, Fidler S, Frater J; the SPARTAC Trial Investigators. Martin GE, et al. Among authors: stohr w. AIDS. 2017 Feb 20;31(4):477-484. doi: 10.1097/QAD.0000000000001382. AIDS. 2017. PMID: 28060012 Free PMC article. Clinical Trial.

7

Virological remission after antiretroviral therapy interruption in female African HIV seroconverters.

Gossez M, Martin GE, Pace M, Ramjee G, Premraj A, Kaleebu P, Rees H, Inshaw J, Stöhr W, Meyerowitz J, Hopkins E, Jones M, Hurst J, Porter K, Babiker A, Fidler S, Frater J; SPARTAC Trial Investigators. Gossez M, et al. Among authors: stohr w. AIDS. 2019 Feb 1;33(2):185-197. doi: 10.1097/QAD.0000000000002044. AIDS. 2019. PMID: 30325764 Free article.

8

Protease inhibitor monotherapy for long-term management of HIV infection: a randomised, controlled, open-label, non-inferiority trial.

Paton NI, Stöhr W, Arenas-Pinto A, Fisher M, Williams I, Johnson M, Orkin C, Chen F, Lee V, Winston A, Gompels M, Fox J, Scott K, Dunn DT; Protease Inhibitor Monotherapy Versus Ongoing Triple Therapy (PIVOT) Trial Team. Paton NI, et al. Among authors: stohr w. Lancet HIV. 2015 Oct;2(10):e417-26. doi: 10.1016/S2352-3018(15)00176-9. Epub 2015 Sep 14. Lancet HIV. 2015. PMID: 26423649 Free PMC article. Clinical Trial.

9

Brain Perfusion, Regional Volumes, and Cognitive Function in Human Immunodeficiency Virus-positive Patients Treated With Protease Inhibitor Monotherapy.

Haddow LJ, Godi C, Sokolska M, Cardoso MJ, Oliver R, Winston A, Stöhr W, Clarke A, Chen F, Williams IG, Johnson M, Paton N, Arenas-Pinto A, Golay X, Jäger HR. Haddow LJ, et al. Among authors: stohr w. Clin Infect Dis. 2019 Mar 5;68(6):1031-1040. doi: 10.1093/cid/ciy617. Clin Infect Dis. 2019. PMID: 30084882

10

Tolerability of four-drug antiretroviral combination therapy in primary HIV-1 infection.

Burns JE, Stöhr W, Kinloch-De Loes S, Fox J, Clarke A, Nelson M, Thornhill J, Babiker A, Frater J, Pett SL, Fidler S. Burns JE, et al. Among authors: stohr w. HIV Med. 2021 Sep;22(8):770-774. doi: 10.1111/hiv.13118. Epub 2021 May 8. HIV Med. 2021. PMID: 33964099 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

88 results

Search Page